Pee Safe, which has scaled rapidly through an omnichannel presence, plans to use the fresh capital to expand retail reach and strengthen its brand.
| Photo Credit:
GRJGM
Venture Catalysts, an integrated incubator and early-stage investment platform, has announced it has taken a full exit from Pee Safe, following the women’s hygiene and wellness brand’s recent $32 million funding led by global healthcare-focused private equity firm OrbiMed.
The secondary component of the round enabled liquidity for select early investors, including Venture Catalysts, converting long-term value creation into cash returns.
Early bet on emerging hygiene segment
Venture Catalysts first backed Pee Safe in August 2017, supporting the company at an early inflection point as it expanded from a focused toilet hygiene proposition into a broad personal hygiene and wellness portfolio.
In June 2017, the company raised pre-series capital from Venture Catalysts, highlighting the firm’s focus on founders with clarity of mission and speed of execution. At the time of investment, organised women’s hygiene innovation was still nascent in India, reflecting Venture Catalysts’ ability to spot underserved consumer categories ahead of mainstream investor attention.
The exit was completed in January 2026, generating a 9.60 multiple on invested capital and an XIRR of 30.53 per cent for the fund and its limited partners.
Pee Safe scales omnichannel presence
Pee Safe has scaled through an omnichannel model, with products available through more than 50,000 offline retail touchpoints across 100+ cities, alongside e-commerce, quick commerce platforms, and its direct-to-consumer channels. The brand has also recorded consistent growth, expanding at approximately 45–50 per cent year-on-year over the last two years.
Fresh funding to fuel expansion
The OrbiMed-led round brings Pee Safe’s total funding to $45.55 million, with investors including Zerodha and Natco Pharma continuing to be part of the company’s investor base. The company plans to use the capital to expand offline retail presence, strengthen brand-led marketing, and deepen reach across quick commerce and major online marketplaces.
Founders highlight value creation and growth journey
Dr Apoorva Ranjan Sharma, Founder, Venture Catalysts, said, “This exit is a validation of patient early stage investing where we back founders before the market agrees. Pee Safe built category depth, distribution muscle, and brand trust. Delivering cash returns, not just markups, strengthens our promise to LPs and energizes our next cycle of investments for everyone involved today.”
Vikas Bagaria, Founder, Pee Safe, said, “Venture Catalysts believed in our mission early and were part of our first fund raise. As we welcome OrbiMed and scale faster, we are proud that early partners can realize meaningful outcomes. We see this as proof that strong brands can be built from India.”
Published on March 17, 2026
Source link
#Venture #Catalysts #exits #Pee #Safe #OrbiMedled #funding #clocks #strong #returns
